PDX INSIGHTS
PIONEERING CANCER RESEARCH
Model Details

Patient Information for Model: TCCC-OS57

Model Contact
Model: TCCC-OS57
Model Contact: Nino Rainusso
Institution: TCH Sarcoma PDX Program
Email: ncrainuss@texaschildrens.org

Patient Information
Clinical Timeline


Clinical Information at Collection
Clinical Biomarkers/Mutations
Pathology Information at Collection

Model Information for Model: TCCC-OS57

Model Details - Initial Implantation of Patient Tissue
Mutations (Cancer Gene Census List)
Mutation data is currently not available.

CNV
There are no omics data for this model.


Histology Information for Model: TCCC-OS57
There are no histology images for this model.













Metastasis Information for Model: TCCC-OS57
 
Patient
PDX
Bone
Lung

Patient Treatment Information for Model: TCCC-OS57

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponsePathologic ResponseReason Stopped
10Methotrexate, Doxorubicin, CisplatinNeoadjuvant16.1616.3362 daysPartial responsePoor response (80% tumor necrosis)Surgical resection (local control)
20Methotrexate, Doxorubicin, CisplatinAdjuvant16.3316.83183 daysNo evidence of diseaseEnd of therapy
30No ChemotherapyAdjuvant17.6617.661No evidence of diseaseMetastectomy (surgical resection lung metastasis)













Please wait...